Skip to main content

Advertisement

Table 1 The clinical characteristics of EGFR TKI-sensitive and –-resistance lung adenocarcinoma patients

From: Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest

  Clinicopathological Features Number of cases EGFR TKI-sensitive EGFR TKI-resistance p Value
Age (years)
  < 65 14 10 4 0.445
  ≥ 65 13 8 5  
Gender     
 Male 10 5 5 0.162
 Female 17 13 4  
Smoking
 No-smokers 20 14 6 0.622
 Smokers 6 4 2  
Tumor size
 T1/T2 15 10 5 0.675
 T3/T4 9 6 3  
lymphatic metastasis
 Absent 16 10 6 0.449
 Present 11 8 3  
Clinical stage
 IV期 27 18 9  
  1. P value represents the probability from a Chi-square test for different number of EGFR TKI-sensitive and –-resistance cases